| Metric | FY 2025↕ |
|---|---|
| Revenue | $12.3B |
| Cost of Revenue | — |
| Gross Profit | — |
| R&D Expense | — |
| SG&A Expense | $2.6B |
| Operating Income | $-0.1B |
| Net Income | $-0.6B |
| EPS (Basic) | $-0.53 |
| EPS (Diluted) | $-0.53 |
| Metric | FY 2025↕ |
|---|---|
| Total Assets | $43.3B |
| Current Assets | $13.3B |
| Cash & Equivalents | $3.3B |
| Total Liabilities | — |
| Current Liabilities | $10.6B |
| Stockholders' Equity | $11.7B |
| Metric | FY 2025↕ |
|---|---|
| Operating Cash Flow | $0.5B |
| Investing Cash Flow | $-0.2B |
| Capital Expenditures | $0.2B |
| Financing Cash Flow | $-0.9B |